Find the standard you are looking for at Engineering360. Documents are available for purchase from the IHS Standards Store.

1 - 20 of 33 results

ASTM C1674 - STANDARD TEST METHOD FOR FLEXURAL STRENGTH OF ADVANCED CERAMICS WITH ENGINEERED POROSITY (HONEYCOMB CELLULAR CHANNELS) AT AMBIENT TEMPERATURES Organization: ASTM
Date: 2016-12-15
Description: English units are sparsely used in this standard for product definitions and tool descriptions, per the cited references and common practice in the US automotive industry. This standard does not purport to address all of the safety concerns, if any, associated with its use.
CRC - ENDOTHELIAL CYTOSKELETON - ENDOTHELIAL CYTOSKELETON Organization: CRC
Date: 2013-08-28
Description: We dedicate this book to our beloved families: we appreciate their bearing up with us for the time spent by us in the preparation of this book.
CRC - JOINT REPLACEMENT AND BON - JOINT REPLACEMENT AND BONE RESORPTION: PATHOLOGY, BIOMATERIALS AND CLINICAL PRACTICE Organization: CRC
Date: 2005-11-09
Description: This should permit us to critically evaluate the progress we have made and the challenges that stand before us. In Section III-Mechanisms of Peri-implant Bone Loss-we have brought together the strongest proponents of various hypotheses for implant loosening and permitted them to make their case.
CRC - OXYGEN SENSING: RESPONSES - OXYGEN SENSING: RESPONSES AND ADAPTION TO HYPOXIA Organization: CRC
Date: 2003-04-15
Description: Interestingly, at about the same time, I, with Nanduri Prabhakar and Gregg Semenza, finished working on a symposium volume on oxygen sensing and Claude's proposal fell into place for the three of us. We decided to take up the challenge, and this volume was created.
CRC - PHARMACOLOGY AND PATHOPHY - PHARMACOLOGY AND PATHOPHYSIOLOGY OF THE CONTROL OF BREATHING Organization: CRC
Date: 2005-05-24
Description: Thomas Hornbein in 1981 that has served as an essential reference for us during our careers. We are particularly gratified that he has provided a Foreword to this volume.
HHS - 21 CFR PART 830 - UNIQUE DEVICE IDENTIFICATION Organization: HHS
Date: 2014-04-01
Description: Expiration date means the date by which the label of a device states the device must or should be used. FDA, we, or us means the Food and Drug Administration. Federal Food, Drug, and Cosmetic Act means 21 U.S.C. 321 et seq., as amended.
ARMY - MIL-R-51197B - REAGENTS, SOLVENTS, AND TEST PAPERS FOR SAMPLING AND ANALYZING KIT, CBR AGENTS Organization: ARMY
Date: 1976-09-15
Description: MILITARY MIL-STD-105 - Sampling Procedures and Tables for Inspection by Attributes. DRAWINGS US ARMY ARMAMENT COMMAND EDGEWOOD ARSENAL B5-77-209 - Packet, White, Filled.
CRC - CYTOKINES: STRESS AND IMM - CYTOKINES: STRESS AND IMMUNITY - SECOND EDITION Organization: CRC
Date: 2006-10-10
Description: Good loved every minute of life and life returned the compliment. Bob Good has not left us; he has merely gone on ahead, as he always has.
CRC - ATLAS OF INHERITED METABO - ATLAS OF INHERITED METABOLIC DISEASES - 3E Organization: CRC
Date: 2011-12-30
Description: We are grateful to the many physicians who have referred these patients to us and to those who have shared their illustrations with us. We are appreciative of the help of many of our fellows and colleagues who have helped us care for and study these patients.
CRC - CHRONIC RHINOSINUSITIS: P - CHRONIC RHINOSINUSITIS: PATHOGENESIS AND MEDICAL MANAGEMENT Organization: CRC
Date: 2007-05-08
Description: More than ever before, this exercise taught us how little we know, and how much still needs investigation. It also inspired us to search deeper for answers and novel insights into a condition that deserves more attention and better treatments.
CRC - TIGHT JUNCTIONS - TIGHT JUNCTIONS Organization: CRC
Date: 2001-06-26
Description: Dorothy Franco and Elizabeth del Oso for their success in keeping all 69 of us on track and on time.
CRC - ANTIANGIOGENIC CANCER THE - ANTIANGIOGENIC CANCER THERAPY Organization: CRC
Date: 2007-07-25
Description: We are deeply grateful to the many people who have helped us compose this book. The experts who contributed to each chapter are the most authoritative in their respective fields.
CRC - ACID-BASE DISORDERS AND T - ACID-BASE DISORDERS AND THEIR TREATMENT Organization: CRC
Date: 2005-08-09
Description: Preface Over twenty years ago, two of us (Nicolaos E. Madias and F. John Gennari) were fortunate to contribute to writing a unique book, entitled Acid–Base.
CRC - XITH INTERNATIONAL SYMPOS - XITH INTERNATIONAL SYMPOSIUM ON AMYLOIDOSIS Organization: CRC
Date: 2007-07-23
Description: We enjoyed a tour and dinner at the Kennedy Museum and Library in Boston on the eve of Election Day in the US. The festive occasion included a welcome by Dr. Karen Antman, Dean of Boston University School of Medicine, and an eloquent after dinner talk by a patient who described her painful experience with AL amyloidosis in 1996 just after her marriage.
CRC - ATLAS OF METABOLIC DISEAS - ATLAS OF METABOLIC DISEASES - SECOND EDITION Organization: CRC
Date: 2005-08-26
Description: We want this book to be helpful to physicians at the bedside, in the intensive care unit and in the clinics and offices, as well as to biochemical geneticists and clinical chemists involved in laboratory diagnosis. The atlas format has permitted us to include very many illustrations of patients.Metabolic pathways have been shown with a reductionist or high power view of just that area most relevant to each disease.
MANEY - MATH MODEL OF WELD PH3 - MATHEMATICAL MODELLING OF WELD PHENOMENA 3 Organization: MANEY
Date: 1997-01-01
Description: As ever, Peter Danckwerts and his team at the Institute of Materials have done us proud with the quality of production. We finally would like to thank all those who have participated in this wonderful project by putting their thoughts down on paper.
CRC - VIRAL THERAPY OF HUMAN CA - VIRAL THERAPY OF HUMAN CANCERS Organization: CRC
Date: 2004-12-28
Description: We cite not only the surveillance by innate NK cells that kill virally infected cells and tumor cells and respond first to immunizations of patients with viral oncolysates, but also the immune T cells, which arise after the inception of a tumor. If one of us could document immune T memory cells specifically reactive to tumor-associated antigens in a healthy and tumorfree individual who never had any documented cancer before, would this finding be acceptable as a proof for the rejection of an incipient tumor in that individual?
CRC - EPIL - EPILEPSY: MECHANISMS, MODELS, AND TRANSLATIONAL PERSPECTIVES Organization: CRC
Date: 2010-06-18
Description: Additionally, we thank the publisher and our families for the support they have given us throughout this project. Finally, we acknowledge the expert editorial and administrative assistance provided by Pat Roberson and Heather Milligan.
CRC - CLINICAL NUTRITION AND AG - CLINICAL NUTRITION AND AGING: SARCOPENIA AND MUSCLE METABOLISM Organization: CRC
Date: 2016-02-24
Description: This gradual loss of muscle is perceived by most of us as “normal.” To an extent this is true—and yet not everybody gets as weak and frail.
CRC - CHROMOSOMAL INSTABILITY A - CHROMOSOMAL INSTABILITY AND AGING: BASIC SCIENCE AND CLINICAL IMPLICATIONS Organization: CRC
Date: 2003-01-29
Description: Fortunately, the Internet has emerged as a means of rapid dissemination of scientific information. One of us (GMM) has been crucial in launching a site devoted to aging research.

1 - 20 of 33 results